Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease
about
Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients.Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors.Decreased plasma soluble erythropoietin receptor in high-altitude excessive erythrocytosis and Chronic Mountain SicknessIL12Rβ1ΔTM is a secreted product of il12rb1 that promotes control of extrapulmonary tuberculosisResistance of dialyzed patients to erythropoietin.Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and AnemiaNew genetic and physiological factors for excessive erythrocytosis and Chronic Mountain SicknessCharacterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma developmentPlasma soluble erythropoietin receptor is decreased during sleep in Andean highlanders with Chronic Mountain SicknessThe erythropoietin receptor is not required for the development, function, and aging of rods and cells in the retinal periphery.Biotherapeutic bioanalysis: a multi-indication case study review.Statins, inflammation and kidney disease.The systemic vascular resistance response: a cardiovascular response modulating blood viscosity with implications for primary hypertension and certain anemias.Alternative Splicing in CKD.Red blood cell abnormalities and the pathogenesis of anemia in end-stage renal disease.Erythropoietin and co.: intrinsic structure and functional disorder.Erythropoietin and Soluble Erythropoietin Receptor: A Role for Maternal Vascular Adaptation to High-Altitude Pregnancy.Alternative Erythropoietin Receptors in the Nervous System.
P2860
Q33625452-61A7535F-16C8-4DB7-81C6-8F7F4759A057Q34094710-291A7148-4121-4052-AD9A-3C548B479E6DQ34626922-34CD02A4-E7D8-4895-84E9-2A9357413DE4Q34955491-03E3737C-EBA2-40AF-A6F7-ABC3FADBCF69Q35694046-6BF92B59-7C70-4AE7-A9D6-4923F9AD7C8AQ35893998-4EBFF188-D71B-4A4F-9C1D-CF1A3CC830B7Q36382218-5E8704D2-6C75-4A46-96DC-C81769C07CCEQ36611934-221499FE-22CC-4724-9E33-E6E3030E1A52Q37139761-0449E586-6046-4C05-A32B-0392BB3D1921Q37639378-F1FF33B3-946F-4981-9B41-03809F4D9EE6Q37854629-872F129F-3C74-4525-99A5-457DF6BF45BCQ37883015-C66018AB-2259-4312-ADC4-3B891B27B20BQ38538916-4589D95F-C463-4838-9369-CD32E4311262Q38695755-9DC39506-15EE-4DF4-8481-F16BA49F95D1Q38762922-25139102-4129-4322-AD2A-FECA881081E6Q39005050-3B9DCD87-D745-4E35-BC21-0D6B4DD18AC2Q40491658-44AA3766-871F-4D02-9F34-16CDDB981B53Q49375977-D49AAA60-F98D-451F-B5BA-13F7D7605B9D
P2860
Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Soluble erythropoietin recepto ...... nce in end-stage renal disease
@ast
Soluble erythropoietin recepto ...... nce in end-stage renal disease
@en
Soluble erythropoietin recepto ...... ce in end-stage renal disease.
@nl
type
label
Soluble erythropoietin recepto ...... nce in end-stage renal disease
@ast
Soluble erythropoietin recepto ...... nce in end-stage renal disease
@en
Soluble erythropoietin recepto ...... ce in end-stage renal disease.
@nl
prefLabel
Soluble erythropoietin recepto ...... nce in end-stage renal disease
@ast
Soluble erythropoietin recepto ...... nce in end-stage renal disease
@en
Soluble erythropoietin recepto ...... ce in end-stage renal disease.
@nl
P2093
P2860
P1433
P1476
Soluble erythropoietin recepto ...... nce in end-stage renal disease
@en
P2093
Eliyahu V Khankin
Hai-Tao Yuan
Hector Tamez
Ravi Thadhani
Walter P Mutter
P2860
P356
10.1371/JOURNAL.PONE.0009246
P407
P577
2010-02-16T00:00:00Z